LEO Pharma

This is the limited version of the LEO Pharma company profile: Join LinkedIn or Sign In to see more information.

Current Company Logo

LEO Pharma is a globally, leading pharmaceutical company within Dermatology and Critical Care.

We maintain a strong focus on developing, manufacturing and marketing safe and efficacious drugs for treating psoriasis and other skin diseases as well as thromboembolic disorders.

LEO Pharma is an independent pharmaceutical company 100 % owned by the LEO Foundation and represented in more than 90 countries and has around 3,000 employees around the world; 1,200 of these in Ballerup, Denmark.

Your Connections to LEO Pharma

To see how you’re connected: Join Now or Sign In

Popular Profiles at LEO Pharma

New Hires and Recent Promotions at LEO Pharma

  • Per. Hyllén, Corporate Vice President Corporate Sales Outcome

    was Salesmanager - this month

  • Kristian Hart-Hansen, Corporate Vice President, Health Outcomes

    was Head of Department, Corporate Pricing & Health Economics - 2 months ago

  • Karsten Sørensen, Corporate Vice President

    was Director, Finished Goods Operations - 2 months ago

  • Per Sprøgel, Vice President, International Clinical Development

    was Director, International Clinical Development - 2 months ago

  • Kristian Lykke Fick, Regional Vice President

    was Director - 2 months ago

To see more new hires & promotions: Join Now or Sign In

Last edited by International Product Manager, Nephrology

In partnership with BusinessWeek

Send feedback on BusinessWeek/CapIQ content to linkedinissues@capitaliq.com. Copyright © 2009 Capital IQ.

This LinkedIn Company Profile was created by LinkedIn and is about LEO Pharma. This page is not endorsed by or affiliated with LEO Pharma. For questions regarding LinkedIn Company Profiles, contact us.

LEO Pharma full company profile, top executives, board of directors & more.